Latest AI and machine learning research in hepatitis for healthcare professionals.
Designing effective vaccination strategies against genetically diverse viruses, such as HIV or influenza, is hindered by the ability of these pathogens to mutate and readily evade immune control. While these viruses contain conserved regions that cannot easily mutate without affecting viral fitness, these sites are subdominant, meaning that they are not the primary target of immune responses elici...
Enzyme engineering is central to developing biocatalysts with improved activity and specificity, yet traditional approaches are often limited by the scale of experimental screening. Here we combine ultrahigh-throughput microfluidic droplet screening with generative machine learning to engineer specificity into an unspecific peroxygenase (UPO) from Aspergillus brasiliensis (AbrUPO). A library of 5e...
Although therapeutic drugs targeting gasdermin (GSDM)-mediated pyroptosis have made remarkable progress in treating various diseases, their potential ...
SARS-CoV-2 continues to spread over the world steadily as opposed to many earlier estimations that it would disappear in less than two years. Even tho...
Laboratory automation enhances experimental throughput and reproducibility, yet widespread adoption is constrained by the expertise required for robot...
This work introduces a modular, open-source computational pipeline for glioblastoma (GBM) vaccine design that integrates omics-based OIP5 target disco...
Swarm intelligence, the collective behaviour of animals such as birds, fish, and ants, arises from simple local interactions and enables survival, eff...
This work introduces a modular, open-source computational pipeline for glioblastoma (GBM) vaccine design that integrates omics-based OIP5 target disco...
Both genotype and imaging data carry entangled information about the phenotypes. Associations between genotypes and phenotypes can be manifested or ab...
Designing protein pockets that target specific ligands is crucial for drug discovery and enzyme engineering. Although deep generative models show prom...
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a highly prevalent condition characterized by fat build-up in the liver and ranges...
Single-cell RNA sequencing technologies have revolutionized our understanding of cellular heterogeneity, yet computational methods often struggle to b...
Early detection of hepatocellular carcinoma (HCC) is critical for improving patient outcomes, yet current screening tools lack sensitivity and specifi...
Melanoma outcomes have dramatically improved over the past decade, but some patients still experience disease recurrence, particularly those who prese...
The selection of an effective adjuvant is a critical bottleneck in vaccine development, particularly for emerging diseases where experimental data is ...
Tuberculosis claims around 1.5 million lives annually. The M72/AS01E vaccine candidate is an innovative effort demonstrating a 50% reduction in the in...
Vaccination against infectious diseases prevents diseases, saves lives, and reduces healthcare costs. However, trust, accessibility, and public percep...
Comprehensively studying modifiable risk factors altogether to explore how they contribute to dementia mechanism is imperative for effective intervent...
Vaccination is a potent means to combat the spread of infectious disease epidemics or pandemics, such as the COVID-19 pandemic. However, getting suffi...
Mass oral cholera vaccination campaigns targeted at subnational areas with high incidence are central to global cholera elimination efforts. Serologic...